Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale

Journal of Pain - United States
doi 10.1016/j.jpain.2015.07.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Chemotherapy-Induced Peripheral Neuropathy

JAMA Oncology
Cancer ResearchOncology
2019English

Longitudinal Assessment of Oxaliplatin-Induced Neuropathy

Neurology
Neurology
2011English

Concomitant Medications and Risk of Chemotherapy‐Induced Peripheral Neuropathy

Oncologist
Cancer ResearchMedicineOncology
2018English

Nutraceuticals for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Nutraceuticals and Innovative Food Products for Healthy Living and Preventive Care
English

Treatment of Chemotherapy – Induced Peripheral Neuropathy: The Physicians Need Guidelines, the Patients Need Help

Journal of Cancer Research Updates
2012English

Factors Associated With the Development and Severity of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Chemotherapy-Induced Peripheral Neuropathy: An Update on the Current Understanding

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Role of Erythropoeitin in Prevention of Chemotherapy-Induced Peripheral Neuropathy

Pakistan Journal of Biological Sciences
AgronomyCrop Science
2010English

The Relationship Between Evaluation Methods for Chemotherapy-Induced Peripheral Neuropathy

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy